A JAMA Network Surgery study found GLP-1 prescriptions up 24% since 2018, while a Tulane surgeon says Louisiana insurance favors surgery.
Recap by typeshit. Full story at www.hometownstations.com.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Bodybuilder Sam Sulek gives his take on peptides in a short clip from Chris Williamson's show. His views are his own, not medical guidance.
Labroots reports Lilly is moving against unauthorized sellers of retatrutide, an obesity drug that has not yet won approval.
Lilly says it has reported over 14,000 listings in more than 100 countries and wants platforms, payment firms and shippers to cut off sales of the unapproved drug.
Loading…